ITMCTR2100005013招募中1 期

Modified Xiaochaihu decoction combined with mirtazapine in the treatment of persistent depression: A pilot randomized controlled trial

The Sixth Medical Center of the General Hospital of the People's Liberation Army, Beijing, China0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Patients who meet the diagnostic criteria of PDD in DSM-5 and are accompanied by symptoms of chronic insomnia or pain;
•2. SDS Self-Rating Scale (compiled by W.Zung in 1965, also known as Zung Self-Rating Depression Scale is one of the scales recommended by the U.S. Department of Education, Health and Welfare for psychopharmacology research. Because it is simple to use, it can reflect patients' subjective feelings of depression and its changes in treatment intuitively. At present, it has been widely used in outpatient rough screening, emotional state assessment, investigation, scientific research, etc. The total score >=41 points;
•3. Aged 24 to 64 years;
•4. Those who can correctly understand the content of the scale.

•1. Patients who received other antidepressant treatment within 2 weeks of the beginning of this study;
•2. Have a history of alcohol and drug dependence;
•3. Pregnant women and lactating women;
•4. Instable control of hypertension, diabetes and other chronic internal diseases;
•5. abnormal liver and kidney function;
•6. Patients with fever, pneumonia, trauma and other diseases.

发起方

The Sixth Medical Center of the General Hospital of the People's Liberation Army, Beijing, China